Related Experiment Videos
Star Polymers Reduce Islet Amyloid Polypeptide Toxicity via Accelerated Amyloid Aggregation.
Emily H Pilkington1, May Lai1, Xinwei Ge2
1ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Monash Institute of Pharmaceutical Sciences, Monash University , 381 Royal Parade, Parkville, Victoria 3052, Australia.
Biomacromolecules
|October 17, 2017
Summary
Star-shaped polymers promote human islet amyloid polypeptide (IAPP) aggregation, reducing its toxicity in type 2 diabetes research. This novel approach accelerates fibrillation, offering a new therapeutic strategy against amyloid diseases.
Area of Science:
- Biochemistry
- Materials Science
- Nanotechnology
Background:
- Protein aggregation into amyloid fibrils is central to neurodegenerative diseases and type 2 diabetes.
- Current strategies focus on inhibiting aggregation, but nature sometimes accelerates it.
Purpose of the Study:
- To design star-shaped poly(2-hydroxyethyl acrylate) (PHEA) nanostructures.
- To promote aggregation of human islet amyloid polypeptide (IAPP) while reducing its toxicity.
Main Methods:
- Utilized star-shaped PHEA nanostructures for IAPP interaction.
- Employed atomistic molecular dynamics simulations.
- Analyzed IAPP aggregate structure and toxicity.
Main Results:
- PHEA binding increased β-sheet content in IAPP aggregates.
- Observed a novel
Conclusions:
- Star polymers can be a new therapeutic agent against amyloidogenesis.
- This study provides new insights into the structure-toxicity relationship of IAPP.